Beperidium iodide
Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
Product Specifications
CAS Number
86434-57-3
Product Name Alternative
SX 810
UNSPSC
12352005
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Beperidium_iodide.html
Purity
99.97
Solubility
DMSO : ≥ 100 mg/mL
Smiles
C[N+]1(CC)CCC(OC(C(C2=NOC3=C2C=CC=C3)N4CCCCCC4)=O)CC1.[I-]
Molecular Formula
C23H34IN3O3
Molecular Weight
527.44
References & Citations
[1]Kawashima K, et al. Pharmacological properties of the novel antimuscarinic agent 4-[2- (1,2-benzisoxazol-3-yl) -2- (hexahydro-1H-azepin-1-yl) a cetoxy]-1-et hyl-1- methylpiperidinium iodide. Arzneimittelforschung. 1986 Jun;36 (6) :927-35.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
252401 100 µg
TAZ (tafazzin, BTHS, CMD3A, EFE, EFE2, FLJ27390, G4.5, LVNCX, Taz1, XAP-2)
Sign In for Pricing
View Details 
